Related Experiment Video
Updated: Jul 9, 2026

High-Resolution Neutron Spectroscopy to Study Picosecond-Nanosecond Dynamics of Proteins and Hydration Water
Published on: April 28, 2022
Molecular dynamics studies of alpha-helix stability in fibril-forming peptides
Erik Nordling1, Yvonne Kallberg, Jan Johansson
1Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, 171 77, Sweden. erik.nordling@biovitrum.com
Abstract:
Diseases associated with protein fibril-formation, such as the prion diseases and Alzheimer's disease, are gaining increased attention due to their medical importance and complex origins. Using molecular dynamics (MD) simulations in an aqueous environment, we have studied the stability of the alpha-helix covering positions 15-25 of the amyloid beta-peptide (A beta) involved in Alzheimer's disease. The effects of residue replacements, including the effects of A beta disease related mutations, were also investigated. The MD simulations show a very early (2 ns) loss of alpha-helical structure for the Flemish (A beta(A21G)), Italian (A beta(E22K)), and Iowa (A beta(D23N)) forms associated with hereditary Alzheimer's disease. Similarly, an early (5 ns) loss of alpha-helical structure was observed for the Dutch (A beta(E22Q)) variant. MD here provides a possible explanation for the structural changes. Two variants of A beta, A beta(K16A,L17A,F20A) and A beta(V18A,F19A,F20A), that do not produce fibrils in vitro were also investigated. The A beta(V18A,F19A,F20A) initially loses its helical conformation but refolds into helix several times and spends most of the simulation time in helical conformation. However, the A beta(K16A,L17A,F20A) loses the alpha-helical structure after 5 ns and does not refold. For the wildtype A beta(1-40) and A beta(1-42), the helical conformation is lost after 5 ns or after 40 ns, respectively, while for the "familial" (A beta(A42T)) variant, the MD simulations suggest that a C-terminal beta-strand is stabilised, which could explain the fibrillation. The simulations for the Arctic (A beta(E22G)) variant indicate that the alpha-helix is kept for 2 ns, but reappears 2 ns later, whereafter it disappears after 10 ns. The MD results are in several cases compatible with known experimental data, but the correlation is not perfect, indicating that multimerisation tendency and other factors might also be important for fibril formation.
Insights
Molecular dynamics simulations reveal how mutations in amyloid beta-peptide affect its alpha-helical structure, offering insights into Alzheimer's disease pathogenesis. These findings help explain early structural changes linked to hereditary forms of the disease.
Area of Science:
- Biophysics
- Computational Biology
- Neuroscience
Background:
- Protein misfolding and fibril formation are implicated in neurodegenerative diseases like Alzheimer's.
- Amyloid beta-peptide (A beta) aggregation is a key pathological hallmark of Alzheimer's disease.
Purpose of the Study:
- To investigate the stability of the alpha-helix in amyloid beta-peptide (A beta) using molecular dynamics (MD) simulations.
- To examine the impact of various A beta mutations on its structural conformation and potential link to fibril formation.
Main Methods:
- Utilized molecular dynamics (MD) simulations in an aqueous environment to study A beta peptide structure.
- Analyzed the effects of specific residue replacements and known disease-related mutations on A beta's alpha-helical stability.
Main Results:
- Hereditary Alzheimer's disease mutations (Flemish, Italian, Iowa, Dutch) rapidly destabilized the A beta alpha-helix.
- Investigated variants designed to inhibit fibril formation, observing varied helical stability and refolding.
- Wildtype A beta and familial variants showed distinct helical loss patterns, with one variant stabilizing a beta-strand, potentially promoting fibrillation.
Conclusions:
- MD simulations provide mechanistic insights into how A beta mutations alter alpha-helical structure, contributing to Alzheimer's disease.
- Observed structural changes correlate with experimental data but highlight the need to consider other factors like multimerization in fibril formation.
Related Concept Videos
Protein Folding
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Protein Folding
Protein Folding
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Molecular Chaperones and Protein Folding
The...

